Towards precision medicine for non-small cell lung cancer

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1110820

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Better outcomes are needed for lung cancer, a disease that accounts for more cancer-related deaths than any other cancer in Australia or worldwide. My goals are to 1) develop and evaluate in clinical trials targeted therapies and immunotherapies and 2) identify clinically relevant blood and tissue based biomarkers for lung cancer patients. This combination of clinical and translational research will change practice and improve outcomes by delivering precision medicine for lung cancer patients.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2019

Funding Scheme: Career Development Fellowships

Funding Amount: $463,652.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Molecular Targets

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

clinical research | clinical trial | immunology | molecular markers | non-small cell lung cancer

Related Links